1,392
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Prioritizing and implementing HPV vaccination quality improvement programs in healthcare systems: the perspective of quality improvement leaders

ORCID Icon, , , , &
Pages 3577-3586 | Received 02 Feb 2021, Accepted 31 Mar 2021, Published online: 21 Jun 2021

References

  • Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Cheryl Bañez Ocfemia M, Su J, Xu F, Weinstock H. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187–93. doi:10.1097/OLQ.0b013e318286bb53.
  • Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human papillomavirus–attributable cancers — United States, 2012–2016. MMWR Morb Mortal Wkly Rep. 2019;68(33):724–28. doi:10.15585/mmwr.mm6833a3.
  • Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, Fredua B, McNamara L, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2019. Morb Mortal Wkly Rep [Internet] 2020; 69:1109–16. https://www.cdc.gov/mmwr/volumes/69/wr/mm6933a1.htm.
  • Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, Gee J, Glover M, Herring B, Kang Y, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration — United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(19):591–93. doi:10.15585/mmwr.mm6919e2.
  • Bramer CA, Kimmins LM, Swanson R, Kuo J, Vranesich P, Jacques-Carroll LA, Shen AK. Decline in child vaccination coverage during the COVID-19 pandemic — Michigan care improvement registry, May 2016–May 2020. MMWR Morb Mortal Wkly Rep. 2020;69(20):630–31. doi:10.15585/mmwr.mm6920e1.
  • Hart C. The effect of COIV-19 on immunization rates. Confessions Pediatr Pract Manage Consult [Internet]. 2020 [accessed 2020 Dec 17]. https://chipsblog.pcc.com/the-effect-of-covid-19-on-immunization-rates.
  • Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34:1187–92. doi:10.1016/j.vaccine.2016.01.023.
  • Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1673–79. doi:10.1158/1055-9965.EPI-15-0326.
  • Gilkey MB, McRee AL. Provider communication about HPV vaccination: a systematic review. Hum Vaccines Immunother. 2016;12:1454–68. doi:10.1080/21645515.2015.1129090.
  • Perkins RB, Clark JA, Apte G, Vercruysse JL, Sumner JJ, Wall-Haas CL, Rosenquist AW, Pierre-Joseph N. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics. 2014;134(3):e666–e674. doi:10.1542/peds.2014-0442.
  • Hughes CC, Jones AL, Feemster KA, Fiks AG. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr. 2011;11(1). doi:10.1186/1471-2431-11-74.
  • Zimet GD, Stupiansky NW, Weiss TW, Rosenthal SL, Good MB, Vichnin MD. Influence of patient’s relationship status and HPV history on physicians’ decisions to recommend HPV vaccination. Vaccine. 2011;29:378–81. doi:10.1016/j.vaccine.2010.11.027.
  • Vadaparampil ST, Malo TL, Sutton SK, Ali KN, Kahn JA, Casler A, Salmon D, Walkosz B, Roetzheim RG, Zimet GD, et al. Missing the target for routine human papillomavirus vaccination: consistent and strong physician recommendations are lacking for 11- to 12-year-old males. Cancer Epidemiol Biomarkers Prev. 2016;25(10):1435–46. doi:10.1158/1055-9965.EPI-15-1294.
  • Dempsey AF, Pyrzanowski J, Lockhart S, Campagna E, Barnard J, O’Leary ST. Parents’ perceptions of provider communication regarding adolescent vaccines. Hum Vaccines Immunother. 2016;12(6):1469–75. doi:10.1080/21645515.2016.1147636.
  • Kulczycki A, Qu H, Shewchuk R. Primary care physicians’ adherence to guidelines and their likelihood to prescribe the human papillomavirus vaccine for 11- and 12-year-old girls. Womens Health Issues. 2016;26:34–39. doi:10.1016/j.whi.2015.07.012.
  • Shay LA, Baldwin AS, Betts AC, Marks EG, Higashi RT, Street RL, Persaud D, Tiro JA. Parent-provider communication of hpv vaccine hesitancy. Pediatrics. 2018;141(6):e20172312. doi:10.1542/peds.2017-2312.
  • Fenton AT, Eun TJ, Clark JA, Perkins RB. Indicated or elective? The association of providers‘ words with HPV vaccine receipt. Hum Vaccines Immunother. 2018;14(10):2503–09. doi:10.1080/21645515.2018.1480237.
  • Allison MA, Hurley LP, Markowitz L, Crane LA, Brtnikova M, Beaty BL, Snow M, Cory J, Stokley S, Roark J, et al. Primary care physicians perspectives about HPV vaccine. Pediatrics. 2016;137(2):e20152488–e20152488. doi:10.1542/peds.2015-2488.
  • Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1):e20161764. doi:10.1542/peds.2016-1764.
  • Dempsey AF, Pyrznawoski J, Lockhart S, Barnard J, Campagna EJ, Garrett K, Fisher A, Dickinson LM, O’Leary ST. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination a cluster randomized clinical trial. JAMA Pediatr. 2018;172:e180016. doi:10.1001/jamapediatrics.2018.0016.
  • Wilkinson TA, Dixon BE, Xiao S, Tu W, Lindsay B, Sheley M, Dugan T, Church A, Downs SM, Zimet G. Physician clinical decision support system prompts and administration of subsequent doses of HPV vaccine: a randomized clinical trial. Vaccine. 2019;37(31):4414–18. doi:10.1016/j.vaccine.2019.05.004.
  • Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, Hughes CC, Massey J, Keren R, Bell LM, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics. 2013;131(6):1114–24. doi:10.1542/peds.2012-3122.
  • Gilkey MB, Dayton AM, Moss JL, Sparks AC, Grimshaw AH, Bowling JM, Brewer NT. Increasing provision of adolescent vaccines in primary care: a randomized controlled trial. Pediatrics. 2014;134:e346–53. doi:10.1542/peds.2013-4257.
  • Rand CM, Schaffer SJ, Dhepyasuwan N, Blumkin A, Albertin C, Serwint JR, Darden PM, Humiston SG, Mann KJ, Stratbucker W, et al. Provider communication, prompts, and feedback to improve HPV vaccination rates in resident clinics. Pediatrics. 2018;141(4):e20170498. doi:10.1542/peds.2017-0498.
  • Rand CM, Tyrrell H, Wallace-Brodeur R, Goldstein NPN, Darden PM, Humiston SG, Albertin CS, Stratbucker W, Schaffer SJ, Davis W, et al. A learning collaborative model to improve human papillomavirus vaccination rates in primary care. Acad Pediatr. 2018;18:S46–S52. doi:10.1016/j.acap.2018.01.003.
  • Perkins RB, Legler A, Jansen E, Bernstein J, Pierre-Joseph N, Eun TJ, Biancarelli DL, Schuch TJ, Leschly K, Fenton ATHR, et al. Improving HPV vaccination rates: a stepped-wedge randomized trial. Pediatrics. 2020;146(1):e20192737. doi:10.1542/peds.2019-2737.
  • American Academy of Pediatrics. Periodic survey: cross-survey results and findings [Internet]. 2021; [accessed 2020 April 22]. https://www.aap.org/en-us/professional-resources/Research/pediatrician-surveys/Pages/Periodic-Survey-List-of-Surveys-and-Summary-of-Findings.aspx.
  • Mostashari F. The paradox of size: how small, independent practices can thrive in value-based care. Ann Fam Med. 2016;14:5–7. doi:10.1370/afm.1899.
  • Muhlestein DB, Smith NJ. Physician consolidation: rapid movement from small to large group practices, 2013–15. Health Aff. 2016;35:1638–42. doi:10.1377/hlthaff.2016.0130.
  • NCQA. Immunizations for adolescents [Internet]. 2021; [accessed 2020 April 22]. https://www.ncqa.org/hedis/measures/immunizations-for-adolescents/.
  • Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health Ment Health Serv Res. 2015;42:533–44. doi:10.1007/s10488-013-0528-y.
  • Guest G, MacQueen K, Namey E. Applied thematic analysis. 2014.
  • Tsai Y, Lindley MC, Zhou F, Stokley S. Provider payments and the receipt of human papillomavirus vaccine among privately insured adolescents. Health Aff. 2018;37(10):1587–95. doi:10.1377/hlthaff.2018.0545.
  • Malo TL, Hall ME, Brewer NT, Lathren CR, Gilkey MB. Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation. Implement Sci. 2018;13. doi:10.1186/s13012-018-0743-8.
  • Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JML, Cummings T, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis [Internet]. 2015 [accessed 2021 Mar 16];15:565–80. https://pubmed.ncbi.nlm.nih.gov/25744474/.
  • Escoffery C, Riehman K, Watson L, Priess AS, Borne MF, Halpin SN, Rhiness C, Wiggins E, Kegler MC. Facilitators and barriers to the implementation of the HPV VACs (Vaccinate adolescents against cancers) program: a consolidated framework for implementation research analysis. Prev Chronic Dis. 2019;16. doi:10.5888/pcd16.180406.
  • Henrikson NB, Tuzzio L, Gilkey MB, McRee AL. You’re never really off time”: healthcare providers’ interpretations of optimal timing for HPV vaccination. Prev Med Rep. 2016;4:94–97. doi:10.1016/j.pmedr.2016.05.002.
  • American Cancer Society. American Cancer Society: HPV VACs [Internet]. 2019 [accessed 2020 Jan 8]. https://www.mysocietysource.org/sites/HPV/Pages/AboutUs.aspx.
  • Mitchell K, Saraiya M, Bhatt A. Increasing HPV vaccination rates through national provider partnerships. J Womens Health. 2019;28:747–51. doi:10.1089/jwh.2019.7753.
  • Fisher-Borne M, Preiss AJ, Black M, Roberts K, Saslow D. Early outcomes of a multilevel human papillomavirus vaccination pilot intervention in federally qualified health centers. Acad Pediatr. 2018;18:S79–S84. doi:10.1016/j.acap.2017.11.001.
  • National HPV Vaccination Roundtable. Clinician and health systems action guides [Internet]. 2019 [accessed 2021 Jan 8]. https://hpvroundtable.org/action-guides/.
  • Gilkey MB, Bednarczyk RA, Gerend MA, Kornides ML, Perkins RB, Saslow D, Sienko J, Zimet GD, Brewer NT. Getting human papillomavirus vaccination back on track: protecting our national investment in human papillomavirus vaccination in the COVID-19 era. J Adolesc Health. 2020;67(5):633–34. doi:10.1016/j.jadohealth.2020.08.013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.